Suppr超能文献

[肾癌患者血清蛋白的术前和术后变化]

[Pre- and post-operative changes of serum proteins in renal cancer patients].

作者信息

Hisazumi H, Nakajima K, Nishino A, Misaki T, Migita S

出版信息

Hinyokika Kiyo. 1985 Sep;31(9):1519-23.

PMID:4083211
Abstract

Using a micro-single radial immunodiffusion method, quantitative studies have been made on the serum proteins of 30 renal cancer patients; 15 patients without metastasis and 15 patients with metastasis, and expressed by percentage of those obtained on 98 normal volunteers regarded as 100%. Of 45 proteins studied, 4 (Pre, Alb, alpha 2HS and Tf) significantly decreased and 10 (alpha 1AT, alpha 1AG, alpha 1X, Hp, Cp, C9, C5, beta 2III, C4 and C3PA) significantly increased before nephrectomy in both patient groups. In postoperative follow-up studies of the non-metastasis patient group, Pre, Alb and alpha 2HS increased, while alpha 1AT, alpha 1AG, Hp, C9, C5, beta 2III, C4 and C3PA decreased, and normal levels were attained within 6 months after nephrectomy. In the metastasis patient group, no significant changes of these serum proteins were observed. Serum proteins showing significant difference between the 2 patient groups were more prominent 6 months after nephrectomy, namely, the majority of the dysproteinemia caused by the presence of renal cancer did not disappear even 1 month after extirpation of the tumor. alpha 1AT was normalized 1 month after nephrectomy at a highly significant difference, P less than 0.001, and considered one of the promising proteins in terms of clinical course evaluation. As a new finding, renal cancer group with metastasis showed a decrease of FN postoperatively suggesting increase of a fibrin deposition and fibrinogen metabolism in cancer tissue.

摘要

采用微量单向放射免疫扩散法,对30例肾癌患者的血清蛋白进行了定量研究;其中15例无转移患者和15例有转移患者,并以98名正常志愿者的检测结果为100%,用百分比表示。在所研究的45种蛋白质中,两组患者在肾切除术前,有4种(前白蛋白、白蛋白、α2HS糖蛋白和转铁蛋白)显著降低,10种(α1抗胰蛋白酶、α1抗糜蛋白酶、α1X蛋白、触珠蛋白、铜蓝蛋白、C9、C5、β2微球蛋白、C4和C3PA)显著升高。在无转移患者组的术后随访研究中,前白蛋白、白蛋白和α2HS糖蛋白升高,而α1抗胰蛋白酶、α1抗糜蛋白酶、触珠蛋白、C9、C5、β2微球蛋白、C4和C3PA降低,肾切除术后6个月内达到正常水平。在有转移患者组中,未观察到这些血清蛋白有显著变化。两组患者之间显示出显著差异的血清蛋白在肾切除术后6个月更为明显,即即使在肿瘤切除1个月后,由肾癌导致的大多数蛋白异常血症仍未消失。α1抗胰蛋白酶在肾切除术后1个月恢复正常,差异极显著,P<0.001,被认为是临床病程评估中有前景的蛋白之一。作为一项新发现,有转移的肾癌组术后纤维连接蛋白降低,提示癌组织中纤维蛋白沉积和纤维蛋白原代谢增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验